Isthmus Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13M Buy
33,227
+612
+2% +$259K 1.25% 29
2026
Q1
$15.4M Sell
32,615
-3,454
-10% -$1.74M 1.62% 15
2025
Q4
$16.8M Sell
36,069
-453
-1% -$210K 1.87% 10
2025
Q3
$15.6M Sell
36,522
-414
-1% -$160K 3.45% 5
2025
Q2
$14.2M Buy
36,936
+235
+0.6% +$84.7K 1.65% 19
2025
Q1
$12.7M Buy
36,701
+850
+2% +$273K 1.59% 22
2024
Q4
$10.8M Sell
35,851
-122
-0.3% -$42.6K 1.31% 37
2024
Q3
$14.6M Buy
35,973
+35
+0.1% +$12.8K 1.74% 19
2024
Q2
$11.5M Buy
+35,938
New +$11.7M 1.36% 34
2015
Q4
Sell
-184
Closed -$14K 267
2015
Q3
$14K Hold
184
0.01% 231
2015
Q2
$17K Buy
+184
New +$14.7K 0.01% 225

Other funds holding HCA

Isthmus Partners's HCA Position: Q2 2026 in Review

Isthmus Partners increased its HCA Healthcare (HCA) stake by 1.9% in Q2 2026, buying an estimated $259K and bringing the position to 33,227 shares worth $13M. The position accounts for 1.25% of the portfolio, ranked #29.

Isthmus Partners first reported a position in HCA in Q2 2015 and has held it in 11 quarters since. The position peaked at $16.8M in Q4 2025. 342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Isthmus Partners held 33,227 shares of HCA Healthcare worth $13M as of Q2 2026.
  • Isthmus Partners bought 612 HCA Healthcare shares in Q2 2026, an estimated $259K.
  • HCA Healthcare made up 1.25% of Isthmus Partners's portfolio in Q2 2026, its #29 holding.
  • Isthmus Partners first reported a position in HCA Healthcare in Q2 2015 and has held it in 11 quarters since.
  • Isthmus Partners's HCA Healthcare position peaked at $16.8M in Q4 2025.
  • 342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Isthmus Partners's 13F filing for Q2 2026, filed 20 Jul 2026.